Request for Covid-19 Impact Assessment of this Report
The United States Olmesartan API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Olmesartan API market, reaching US$ million by the year 2028. As for the Europe Olmesartan API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Olmesartan API players cover Coba Pharma, Acura Labs, Interquim, and Euro API, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Olmesartan API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Purity 99%
Purity > 99%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Tablet Products
Capsule Products
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Coba Pharma
Acura Labs
Interquim
Euro API
Biophore India Pharmaceuticals
Jai Radhe
Summit Pharmaceuticals Europe
Octavius Pharma Pvt. Ltd
Zeon Health lndustries
Sanofi
Glenmark Pharmaceuticals Europe
Verdant Pharma
Hubei Yitai Pharmaceuticals
Ulkar Kimya
Zhejiang Tianyu Pharmaceutical
Teva API
Zhejiang Huahai Pharmaceutical
Venkata Narayana Active Ingredients
Cadila Pharmaceuticals
Unimark Remedies
Vasudha Pharma
Macleods Pharmaceuticals
Mylan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Olmesartan API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Olmesartan API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Olmesartan API by Country/Region, 2017, 2022 & 2028
2.2 Olmesartan API Segment by Type
2.2.1 Purity 99%
2.2.2 Purity > 99%
2.3 Olmesartan API Sales by Type
2.3.1 Global Olmesartan API Sales Market Share by Type (2017-2022)
2.3.2 Global Olmesartan API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Olmesartan API Sale Price by Type (2017-2022)
2.4 Olmesartan API Segment by Application
2.4.1 Tablet Products
2.4.2 Capsule Products
2.4.3 Others
2.5 Olmesartan API Sales by Application
2.5.1 Global Olmesartan API Sale Market Share by Application (2017-2022)
2.5.2 Global Olmesartan API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Olmesartan API Sale Price by Application (2017-2022)
3 Global Olmesartan API by Company
3.1 Global Olmesartan API Breakdown Data by Company
3.1.1 Global Olmesartan API Annual Sales by Company (2020-2022)
3.1.2 Global Olmesartan API Sales Market Share by Company (2020-2022)
3.2 Global Olmesartan API Annual Revenue by Company (2020-2022)
3.2.1 Global Olmesartan API Revenue by Company (2020-2022)
3.2.2 Global Olmesartan API Revenue Market Share by Company (2020-2022)
3.3 Global Olmesartan API Sale Price by Company
3.4 Key Manufacturers Olmesartan API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Olmesartan API Product Location Distribution
3.4.2 Players Olmesartan API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Olmesartan API by Geographic Region
4.1 World Historic Olmesartan API Market Size by Geographic Region (2017-2022)
4.1.1 Global Olmesartan API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Olmesartan API Annual Revenue by Geographic Region
4.2 World Historic Olmesartan API Market Size by Country/Region (2017-2022)
4.2.1 Global Olmesartan API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Olmesartan API Annual Revenue by Country/Region
4.3 Americas Olmesartan API Sales Growth
4.4 APAC Olmesartan API Sales Growth
4.5 Europe Olmesartan API Sales Growth
4.6 Middle East & Africa Olmesartan API Sales Growth
5 Americas
5.1 Americas Olmesartan API Sales by Country
5.1.1 Americas Olmesartan API Sales by Country (2017-2022)
5.1.2 Americas Olmesartan API Revenue by Country (2017-2022)
5.2 Americas Olmesartan API Sales by Type
5.3 Americas Olmesartan API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Olmesartan API Sales by Region
6.1.1 APAC Olmesartan API Sales by Region (2017-2022)
6.1.2 APAC Olmesartan API Revenue by Region (2017-2022)
6.2 APAC Olmesartan API Sales by Type
6.3 APAC Olmesartan API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Olmesartan API by Country
7.1.1 Europe Olmesartan API Sales by Country (2017-2022)
7.1.2 Europe Olmesartan API Revenue by Country (2017-2022)
7.2 Europe Olmesartan API Sales by Type
7.3 Europe Olmesartan API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Olmesartan API by Country
8.1.1 Middle East & Africa Olmesartan API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Olmesartan API Revenue by Country (2017-2022)
8.2 Middle East & Africa Olmesartan API Sales by Type
8.3 Middle East & Africa Olmesartan API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Olmesartan API
10.3 Manufacturing Process Analysis of Olmesartan API
10.4 Industry Chain Structure of Olmesartan API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Olmesartan API Distributors
11.3 Olmesartan API Customer
12 World Forecast Review for Olmesartan API by Geographic Region
12.1 Global Olmesartan API Market Size Forecast by Region
12.1.1 Global Olmesartan API Forecast by Region (2023-2028)
12.1.2 Global Olmesartan API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Olmesartan API Forecast by Type
12.7 Global Olmesartan API Forecast by Application
13 Key Players Analysis
13.1 Coba Pharma
13.1.1 Coba Pharma Company Information
13.1.2 Coba Pharma Olmesartan API Product Offered
13.1.3 Coba Pharma Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Coba Pharma Main Business Overview
13.1.5 Coba Pharma Latest Developments
13.2 Acura Labs
13.2.1 Acura Labs Company Information
13.2.2 Acura Labs Olmesartan API Product Offered
13.2.3 Acura Labs Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Acura Labs Main Business Overview
13.2.5 Acura Labs Latest Developments
13.3 Interquim
13.3.1 Interquim Company Information
13.3.2 Interquim Olmesartan API Product Offered
13.3.3 Interquim Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Interquim Main Business Overview
13.3.5 Interquim Latest Developments
13.4 Euro API
13.4.1 Euro API Company Information
13.4.2 Euro API Olmesartan API Product Offered
13.4.3 Euro API Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Euro API Main Business Overview
13.4.5 Euro API Latest Developments
13.5 Biophore India Pharmaceuticals
13.5.1 Biophore India Pharmaceuticals Company Information
13.5.2 Biophore India Pharmaceuticals Olmesartan API Product Offered
13.5.3 Biophore India Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biophore India Pharmaceuticals Main Business Overview
13.5.5 Biophore India Pharmaceuticals Latest Developments
13.6 Jai Radhe
13.6.1 Jai Radhe Company Information
13.6.2 Jai Radhe Olmesartan API Product Offered
13.6.3 Jai Radhe Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Jai Radhe Main Business Overview
13.6.5 Jai Radhe Latest Developments
13.7 Summit Pharmaceuticals Europe
13.7.1 Summit Pharmaceuticals Europe Company Information
13.7.2 Summit Pharmaceuticals Europe Olmesartan API Product Offered
13.7.3 Summit Pharmaceuticals Europe Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Summit Pharmaceuticals Europe Main Business Overview
13.7.5 Summit Pharmaceuticals Europe Latest Developments
13.8 Octavius Pharma Pvt. Ltd
13.8.1 Octavius Pharma Pvt. Ltd Company Information
13.8.2 Octavius Pharma Pvt. Ltd Olmesartan API Product Offered
13.8.3 Octavius Pharma Pvt. Ltd Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Octavius Pharma Pvt. Ltd Main Business Overview
13.8.5 Octavius Pharma Pvt. Ltd Latest Developments
13.9 Zeon Health lndustries
13.9.1 Zeon Health lndustries Company Information
13.9.2 Zeon Health lndustries Olmesartan API Product Offered
13.9.3 Zeon Health lndustries Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Zeon Health lndustries Main Business Overview
13.9.5 Zeon Health lndustries Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Olmesartan API Product Offered
13.10.3 Sanofi Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Glenmark Pharmaceuticals Europe
13.11.1 Glenmark Pharmaceuticals Europe Company Information
13.11.2 Glenmark Pharmaceuticals Europe Olmesartan API Product Offered
13.11.3 Glenmark Pharmaceuticals Europe Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Glenmark Pharmaceuticals Europe Main Business Overview
13.11.5 Glenmark Pharmaceuticals Europe Latest Developments
13.12 Verdant Pharma
13.12.1 Verdant Pharma Company Information
13.12.2 Verdant Pharma Olmesartan API Product Offered
13.12.3 Verdant Pharma Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Verdant Pharma Main Business Overview
13.12.5 Verdant Pharma Latest Developments
13.13 Hubei Yitai Pharmaceuticals
13.13.1 Hubei Yitai Pharmaceuticals Company Information
13.13.2 Hubei Yitai Pharmaceuticals Olmesartan API Product Offered
13.13.3 Hubei Yitai Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hubei Yitai Pharmaceuticals Main Business Overview
13.13.5 Hubei Yitai Pharmaceuticals Latest Developments
13.14 Ulkar Kimya
13.14.1 Ulkar Kimya Company Information
13.14.2 Ulkar Kimya Olmesartan API Product Offered
13.14.3 Ulkar Kimya Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Ulkar Kimya Main Business Overview
13.14.5 Ulkar Kimya Latest Developments
13.15 Zhejiang Tianyu Pharmaceutical
13.15.1 Zhejiang Tianyu Pharmaceutical Company Information
13.15.2 Zhejiang Tianyu Pharmaceutical Olmesartan API Product Offered
13.15.3 Zhejiang Tianyu Pharmaceutical Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Zhejiang Tianyu Pharmaceutical Main Business Overview
13.15.5 Zhejiang Tianyu Pharmaceutical Latest Developments
13.16 Teva API
13.16.1 Teva API Company Information
13.16.2 Teva API Olmesartan API Product Offered
13.16.3 Teva API Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Teva API Main Business Overview
13.16.5 Teva API Latest Developments
13.17 Zhejiang Huahai Pharmaceutical
13.17.1 Zhejiang Huahai Pharmaceutical Company Information
13.17.2 Zhejiang Huahai Pharmaceutical Olmesartan API Product Offered
13.17.3 Zhejiang Huahai Pharmaceutical Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.17.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.18 Venkata Narayana Active Ingredients
13.18.1 Venkata Narayana Active Ingredients Company Information
13.18.2 Venkata Narayana Active Ingredients Olmesartan API Product Offered
13.18.3 Venkata Narayana Active Ingredients Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Venkata Narayana Active Ingredients Main Business Overview
13.18.5 Venkata Narayana Active Ingredients Latest Developments
13.19 Cadila Pharmaceuticals
13.19.1 Cadila Pharmaceuticals Company Information
13.19.2 Cadila Pharmaceuticals Olmesartan API Product Offered
13.19.3 Cadila Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Cadila Pharmaceuticals Main Business Overview
13.19.5 Cadila Pharmaceuticals Latest Developments
13.20 Unimark Remedies
13.20.1 Unimark Remedies Company Information
13.20.2 Unimark Remedies Olmesartan API Product Offered
13.20.3 Unimark Remedies Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Unimark Remedies Main Business Overview
13.20.5 Unimark Remedies Latest Developments
13.21 Vasudha Pharma
13.21.1 Vasudha Pharma Company Information
13.21.2 Vasudha Pharma Olmesartan API Product Offered
13.21.3 Vasudha Pharma Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Vasudha Pharma Main Business Overview
13.21.5 Vasudha Pharma Latest Developments
13.22 Macleods Pharmaceuticals
13.22.1 Macleods Pharmaceuticals Company Information
13.22.2 Macleods Pharmaceuticals Olmesartan API Product Offered
13.22.3 Macleods Pharmaceuticals Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Macleods Pharmaceuticals Main Business Overview
13.22.5 Macleods Pharmaceuticals Latest Developments
13.23 Mylan
13.23.1 Mylan Company Information
13.23.2 Mylan Olmesartan API Product Offered
13.23.3 Mylan Olmesartan API Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Mylan Main Business Overview
13.23.5 Mylan Latest Developments
14 Research Findings and Conclusion
Table 1. Olmesartan API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Olmesartan API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity 99%
Table 4. Major Players of Purity > 99%
Table 5. Global Olmesartan API Sales by Type (2017-2022) & (Tons)
Table 6. Global Olmesartan API Sales Market Share by Type (2017-2022)
Table 7. Global Olmesartan API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Olmesartan API Revenue Market Share by Type (2017-2022)
Table 9. Global Olmesartan API Sale Price by Type (2017-2022) & (US$/Kg)
Table 10. Global Olmesartan API Sales by Application (2017-2022) & (Tons)
Table 11. Global Olmesartan API Sales Market Share by Application (2017-2022)
Table 12. Global Olmesartan API Revenue by Application (2017-2022)
Table 13. Global Olmesartan API Revenue Market Share by Application (2017-2022)
Table 14. Global Olmesartan API Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Olmesartan API Sales by Company (2020-2022) & (Tons)
Table 16. Global Olmesartan API Sales Market Share by Company (2020-2022)
Table 17. Global Olmesartan API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Olmesartan API Revenue Market Share by Company (2020-2022)
Table 19. Global Olmesartan API Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Olmesartan API Producing Area Distribution and Sales Area
Table 21. Players Olmesartan API Products Offered
Table 22. Olmesartan API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Olmesartan API Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Olmesartan API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Olmesartan API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Olmesartan API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Olmesartan API Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Olmesartan API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Olmesartan API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Olmesartan API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 34. Americas Olmesartan API Sales Market Share by Country (2017-2022)
Table 35. Americas Olmesartan API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Olmesartan API Revenue Market Share by Country (2017-2022)
Table 37. Americas Olmesartan API Sales by Type (2017-2022) & (Tons)
Table 38. Americas Olmesartan API Sales Market Share by Type (2017-2022)
Table 39. Americas Olmesartan API Sales by Application (2017-2022) & (Tons)
Table 40. Americas Olmesartan API Sales Market Share by Application (2017-2022)
Table 41. APAC Olmesartan API Sales by Region (2017-2022) & (Tons)
Table 42. APAC Olmesartan API Sales Market Share by Region (2017-2022)
Table 43. APAC Olmesartan API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Olmesartan API Revenue Market Share by Region (2017-2022)
Table 45. APAC Olmesartan API Sales by Type (2017-2022) & (Tons)
Table 46. APAC Olmesartan API Sales Market Share by Type (2017-2022)
Table 47. APAC Olmesartan API Sales by Application (2017-2022) & (Tons)
Table 48. APAC Olmesartan API Sales Market Share by Application (2017-2022)
Table 49. Europe Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 50. Europe Olmesartan API Sales Market Share by Country (2017-2022)
Table 51. Europe Olmesartan API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Olmesartan API Revenue Market Share by Country (2017-2022)
Table 53. Europe Olmesartan API Sales by Type (2017-2022) & (Tons)
Table 54. Europe Olmesartan API Sales Market Share by Type (2017-2022)
Table 55. Europe Olmesartan API Sales by Application (2017-2022) & (Tons)
Table 56. Europe Olmesartan API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Olmesartan API Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Olmesartan API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Olmesartan API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Olmesartan API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Olmesartan API Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Olmesartan API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Olmesartan API Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Olmesartan API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Olmesartan API
Table 66. Key Market Challenges & Risks of Olmesartan API
Table 67. Key Industry Trends of Olmesartan API
Table 68. Olmesartan API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Olmesartan API Distributors List
Table 71. Olmesartan API Customer List
Table 72. Global Olmesartan API Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Olmesartan API Sales Market Forecast by Region
Table 74. Global Olmesartan API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Olmesartan API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Olmesartan API Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Olmesartan API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Olmesartan API Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Olmesartan API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Olmesartan API Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Olmesartan API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Olmesartan API Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Olmesartan API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Olmesartan API Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Olmesartan API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Olmesartan API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Olmesartan API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Olmesartan API Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Olmesartan API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Olmesartan API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Olmesartan API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Coba Pharma Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 93. Coba Pharma Olmesartan API Product Offered
Table 94. Coba Pharma Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Coba Pharma Main Business
Table 96. Coba Pharma Latest Developments
Table 97. Acura Labs Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 98. Acura Labs Olmesartan API Product Offered
Table 99. Acura Labs Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Acura Labs Main Business
Table 101. Acura Labs Latest Developments
Table 102. Interquim Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 103. Interquim Olmesartan API Product Offered
Table 104. Interquim Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Interquim Main Business
Table 106. Interquim Latest Developments
Table 107. Euro API Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 108. Euro API Olmesartan API Product Offered
Table 109. Euro API Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Euro API Main Business
Table 111. Euro API Latest Developments
Table 112. Biophore India Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 113. Biophore India Pharmaceuticals Olmesartan API Product Offered
Table 114. Biophore India Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Biophore India Pharmaceuticals Main Business
Table 116. Biophore India Pharmaceuticals Latest Developments
Table 117. Jai Radhe Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 118. Jai Radhe Olmesartan API Product Offered
Table 119. Jai Radhe Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Jai Radhe Main Business
Table 121. Jai Radhe Latest Developments
Table 122. Summit Pharmaceuticals Europe Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 123. Summit Pharmaceuticals Europe Olmesartan API Product Offered
Table 124. Summit Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Summit Pharmaceuticals Europe Main Business
Table 126. Summit Pharmaceuticals Europe Latest Developments
Table 127. Octavius Pharma Pvt. Ltd Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 128. Octavius Pharma Pvt. Ltd Olmesartan API Product Offered
Table 129. Octavius Pharma Pvt. Ltd Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Octavius Pharma Pvt. Ltd Main Business
Table 131. Octavius Pharma Pvt. Ltd Latest Developments
Table 132. Zeon Health lndustries Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 133. Zeon Health lndustries Olmesartan API Product Offered
Table 134. Zeon Health lndustries Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Zeon Health lndustries Main Business
Table 136. Zeon Health lndustries Latest Developments
Table 137. Sanofi Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 138. Sanofi Olmesartan API Product Offered
Table 139. Sanofi Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Sanofi Main Business
Table 141. Sanofi Latest Developments
Table 142. Glenmark Pharmaceuticals Europe Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 143. Glenmark Pharmaceuticals Europe Olmesartan API Product Offered
Table 144. Glenmark Pharmaceuticals Europe Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Glenmark Pharmaceuticals Europe Main Business
Table 146. Glenmark Pharmaceuticals Europe Latest Developments
Table 147. Verdant Pharma Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 148. Verdant Pharma Olmesartan API Product Offered
Table 149. Verdant Pharma Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 150. Verdant Pharma Main Business
Table 151. Verdant Pharma Latest Developments
Table 152. Hubei Yitai Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 153. Hubei Yitai Pharmaceuticals Olmesartan API Product Offered
Table 154. Hubei Yitai Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 155. Hubei Yitai Pharmaceuticals Main Business
Table 156. Hubei Yitai Pharmaceuticals Latest Developments
Table 157. Ulkar Kimya Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 158. Ulkar Kimya Olmesartan API Product Offered
Table 159. Ulkar Kimya Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 160. Ulkar Kimya Main Business
Table 161. Ulkar Kimya Latest Developments
Table 162. Zhejiang Tianyu Pharmaceutical Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 163. Zhejiang Tianyu Pharmaceutical Olmesartan API Product Offered
Table 164. Zhejiang Tianyu Pharmaceutical Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 165. Zhejiang Tianyu Pharmaceutical Main Business
Table 166. Zhejiang Tianyu Pharmaceutical Latest Developments
Table 167. Teva API Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 168. Teva API Olmesartan API Product Offered
Table 169. Teva API Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 170. Teva API Main Business
Table 171. Teva API Latest Developments
Table 172. Zhejiang Huahai Pharmaceutical Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 173. Zhejiang Huahai Pharmaceutical Olmesartan API Product Offered
Table 174. Zhejiang Huahai Pharmaceutical Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 175. Zhejiang Huahai Pharmaceutical Main Business
Table 176. Zhejiang Huahai Pharmaceutical Latest Developments
Table 177. Venkata Narayana Active Ingredients Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 178. Venkata Narayana Active Ingredients Olmesartan API Product Offered
Table 179. Venkata Narayana Active Ingredients Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 180. Venkata Narayana Active Ingredients Main Business
Table 181. Venkata Narayana Active Ingredients Latest Developments
Table 182. Cadila Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 183. Cadila Pharmaceuticals Olmesartan API Product Offered
Table 184. Cadila Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 185. Cadila Pharmaceuticals Main Business
Table 186. Cadila Pharmaceuticals Latest Developments
Table 187. Unimark Remedies Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 188. Unimark Remedies Olmesartan API Product Offered
Table 189. Unimark Remedies Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 190. Unimark Remedies Main Business
Table 191. Unimark Remedies Latest Developments
Table 192. Vasudha Pharma Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 193. Vasudha Pharma Olmesartan API Product Offered
Table 194. Vasudha Pharma Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 195. Vasudha Pharma Main Business
Table 196. Vasudha Pharma Latest Developments
Table 197. Macleods Pharmaceuticals Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 198. Macleods Pharmaceuticals Olmesartan API Product Offered
Table 199. Macleods Pharmaceuticals Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 200. Macleods Pharmaceuticals Main Business
Table 201. Macleods Pharmaceuticals Latest Developments
Table 202. Mylan Basic Information, Olmesartan API Manufacturing Base, Sales Area and Its Competitors
Table 203. Mylan Olmesartan API Product Offered
Table 204. Mylan Olmesartan API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 205. Mylan Main Business
Table 206. Mylan Latest Developments
List of Figures
Figure 1. Picture of Olmesartan API
Figure 2. Olmesartan API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Olmesartan API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Olmesartan API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Olmesartan API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity 99%
Figure 10. Product Picture of Purity > 99%
Figure 11. Global Olmesartan API Sales Market Share by Type in 2021
Figure 12. Global Olmesartan API Revenue Market Share by Type (2017-2022)
Figure 13. Olmesartan API Consumed in Tablet Products
Figure 14. Global Olmesartan API Market: Tablet Products (2017-2022) & (Tons)
Figure 15. Olmesartan API Consumed in Capsule Products
Figure 16. Global Olmesartan API Market: Capsule Products (2017-2022) & (Tons)
Figure 17. Olmesartan API Consumed in Others
Figure 18. Global Olmesartan API Market: Others (2017-2022) & (Tons)
Figure 19. Global Olmesartan API Sales Market Share by Application (2017-2022)
Figure 20. Global Olmesartan API Revenue Market Share by Application in 2021
Figure 21. Olmesartan API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Olmesartan API Revenue Market Share by Company in 2021
Figure 23. Global Olmesartan API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Olmesartan API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Olmesartan API Sales Market Share by Region (2017-2022)
Figure 26. Global Olmesartan API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Olmesartan API Sales 2017-2022 (Tons)
Figure 28. Americas Olmesartan API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Olmesartan API Sales 2017-2022 (Tons)
Figure 30. APAC Olmesartan API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Olmesartan API Sales 2017-2022 (Tons)
Figure 32. Europe Olmesartan API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Olmesartan API Sales 2017-2022 (Tons)
Figure 34. Middle East & Africa Olmesartan API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Olmesartan API Sales Market Share by Country in 2021
Figure 36. Americas Olmesartan API Revenue Market Share by Country in 2021
Figure 37. United States Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Olmesartan API Sales Market Share by Region in 2021
Figure 42. APAC Olmesartan API Revenue Market Share by Regions in 2021
Figure 43. China Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Olmesartan API Sales Market Share by Country in 2021
Figure 50. Europe Olmesartan API Revenue Market Share by Country in 2021
Figure 51. Germany Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Olmesartan API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Olmesartan API Revenue Market Share by Country in 2021
Figure 58. Egypt Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Olmesartan API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Olmesartan API in 2021
Figure 64. Manufacturing Process Analysis of Olmesartan API
Figure 65. Industry Chain Structure of Olmesartan API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...